H
Loading...
Loading...
CDC PLACES (2023, crude) estimates 6.4% of adults in Ann Arbor have diagnosed diabetes — 5.6 points below the U.S. 12% figure. Census population 123,851. Michigan Medicare wound biologics: WPS Government Health Administrators (J8). Hawk Medical is a national HCT/P 361 and wound-care distributor serving licensed Ann Arbor clinics — not a walk-in office.
Written for licensed providers. Reviewed by Joe Bradley, Founder & CEO. Content version 2026-09-18. Hawk Medical ships nationwide — this is not a Ann Arbor storefront.
Skin Substitute Therapy Products in Ann Arbor, MI for clinics & physicians. Skin substitute therapy for co… Compliance support & pricing — contact Hawk Medical.
CDC PLACES (2023, crude) estimates 6.4% of adults in Ann Arbor have diagnosed diabetes — 5.6 points below the U.S. 12% figure. Obesity 25.8%; arthritis 16.7%. Those three PLACES crude rates (plus Census 123,851) are the local facts on this page. Everything else is the national skin substitute therapy catalog and J8 paperwork.
National Skin Substitute Therapy Products notes (how the product actually works)6% of adults 18–64 here currently lack health insurance (CDC PLACES ACCESS2, 2023). Cash-pay PRP and Medicare CTPs cannot share one consent script. A city under 250k with 123,851 residents will still mix those payers. CDC PLACES (2023, crude) estimates 6.4% of adults in Ann Arbor have diagnosed diabetes — 5.6 points below the U.S. 12% figure. Build two utilization policies if you do both cash PRP and Medicare CTPs.
Practices hire us when the fridge is full and the chart is a mess. CDC PLACES (2023, crude) estimates 6.4% of adults in Ann Arbor have diagnosed diabetes — 5.6 points below the U.S. 12% figure. That is a planning input. The work is still receiving, indication language, and not mixing PRP with CTP codes. That is the skin substitute therapy account.
CDC PLACES (2023, crude prevalence) estimates 6.4% of adults — 5.6 points below the U.S. 12% figure. Obesity is 25.8%; arthritis is 16.7%. That is place-level BRFSS modeling, not a clinic census and not a Ann Arbor trial.
The allograft is used to perform the same basic function in the recipient as in the donor (FDA 361). Using umbilical or amniotic tissue as a marketed “stem cell cure” for unrelated conditions is outside that lane and is a Michigan compliance risk.
Point-of-care spin, kit handling, and documentation basics. Injection technique, privileging, and ultrasound guidance remain the clinic’s clinical education path in Michigan.
No. They are B2B distribution pages for licensed providers. Patients in Ann Arbor should speak with their clinician, not use a distributor URL as care instructions.
Bring specialty, monthly wound volume, and whether you bill J8 FFS, Advantage, workers’ comp, or cash-pay. We already have PLACES 6.4% diabetes and 16.7% arthritis for Ann Arbor — tell us how that matches your panel. Book 15 minutes with Joe or use the contact form.
Contact us to learn how Hawk Medical supports practices in Ann Arbor, MI.
Hawk Medical is a national distributor. Joe Bradley’s clinic uses the same product classes. What is local for Ann Arbor is J8 geography and published epidemiology — not a street address.
CDC PLACES 2023 crude rate for Ann Arbor — 5.6 points below the U.S. 12% figure. Planning input, not an outcomes claim.
Michigan Part B wound biologics follow this contractor (siblings: IN). We train to the articles. We do not write coverage.
PLACES crude adult arthritis in Ann Arbor. Useful for joint-program math; still needs a diagnosis and privileging.
No Ann Arbor storefront. Joe Bradley is an active practice owner. skin substitute therapy stays in its regulatory lane — not “FDA-approved stem cell therapy.”
Experience the difference of working with a distributor who understands your practice because we operate one ourselves.